Evaluation of photodynamic therapy (PDT) procedures using microfluidic system

Anal Chim Acta. 2011 Jan 10;683(2):149-55. doi: 10.1016/j.aca.2010.10.005. Epub 2010 Oct 11.

Abstract

A hybrid PDMS/glass microfluidic system for evaluation of the efficiency of photodynamic therapy is presented. 5-aminolevulinic acid (ALA) was used as a precursor of photosensitizer. The geometry of the microdevice presented in this paper enables to test different concentrations of the photosensitizer in a single assay. The viability of the A549 cells was determined 24 h after PDT procedure (irradiation with light which induced a photosensitizer accumulated in carcinoma cells, λ=625 nm). The presented results confirmed the possibility to perform the photodynamic therapy process in vitro in microscale and the possibility to assess its effectiveness. Moreover, because two identical microstructures on a single chip were performed, the microchip can be used for examination simultaneously various cell lines (carcinoma and normal) or various photosensitizers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminolevulinic Acid / chemistry
  • Aminolevulinic Acid / therapeutic use
  • Aminolevulinic Acid / toxicity
  • Cell Line, Tumor
  • Dimethylpolysiloxanes / chemistry
  • Humans
  • Lab-On-A-Chip Devices
  • Lung Neoplasms / drug therapy
  • Microfluidic Analytical Techniques / instrumentation
  • Microfluidic Analytical Techniques / methods*
  • Photochemotherapy*
  • Photosensitizing Agents / chemistry
  • Photosensitizing Agents / therapeutic use
  • Photosensitizing Agents / toxicity
  • Protoporphyrins / chemistry

Substances

  • Dimethylpolysiloxanes
  • Photosensitizing Agents
  • Protoporphyrins
  • baysilon
  • Aminolevulinic Acid
  • protoporphyrin IX